Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Morgan Stanley on BioMarin Pharmaceutical Inc. (BMRN): 'we think the settlement recognizes the value of BioMarin’s pioneering CNP innovation'
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $105 at Jefferies
-
Stifel: 'we continue to think there's a credible case TECX/TX45 offers the best test of the relaxin hypothesis'
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Neutral Rating on Elastic NV. (ESTC)
-
-
-
-
-
-
-
Raymond James on Malibu Boats (MBUU): 'continued soft retail environment'
-
-
-
-
-
-
-
Affirm Holdings (AFRM) PT Raised to $110 at Bernstein SocGen Group
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
-
-
-
-
-
-
-
Piper Sandler on Lululemon (LULU): 'US Likely Inline, Focus on China/ROW'
-
-
-
-
-
-
-
RBC Capital on The Campbell's Co. (CPB): 'Yet to See Signs of a Meaningful Recovery'
-
-
-
-
-
487,940 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.
